JCU (4975) Q4 2026 earnings summary

Executive summary

• Net sales for FY3/26 (fiscal year ended March 31, 2026) reached ¥29,672 million, a 4.6% increase year-over-year.

• Operating profit rose 15.6% year-over-year to ¥12,156 million.

• Profit attributable to owners of parent increased 21.0% year-over-year to ¥9,074 million.

• Comprehensive income for the year was ¥10,212 million, up from ¥8,853 million the previous year.

Financial highlights

• Ordinary profit grew 14.0% year-over-year to ¥14,141 million.

• Net income per share for FY3/26 was ¥365.74, up from ¥342.43 in FY3/25.

• Equity-to-asset ratio remained strong at 87.1%.

• Cash and cash equivalents at year-end totaled ¥22,009 million, down from ¥24,813 million.

• Positive operating profit drivers included higher sales and profit from chemicals, while negative factors included increased SG&A expenses and decreased gross profit from purchased products.

Outlook and guidance

• FY3/27 net sales forecasted at ¥33,400 million, a 12.6% increase year-over-year.

• Operating profit expected to rise slightly to ¥12,300 million (+1.2% year-over-year).

• Profit attributable to owners of parent projected to decrease 3.0% to ¥8,800 million.

• Net income per share forecasted at ¥357.44 for FY3/27.

• Interim dividend forecast for FY2027 is ¥90.00 per share, with a full-year forecast of ¥180.00 per share.